Optio Biopharma Solutions, LLC
  • Home
  • About Us
  • Services
  • Team
  • Cases
  • News
  • Contact
Surmounting market challenges and exceeding client objectives since 2007.
Optio Biopharma Solutions, LLC
  • Home
  • About Us
  • Services
  • Team
  • Cases
  • News
  • Contact
Office (650) 308 4999
HomeNews
Optio attends Huntington’s Disease Society of America 37th annual convention – Atlanta, June 2022
May 11, 2022
Optio attends CHDI – February 2022, Palm Springs, USA
February 14, 2022
Eric Miller appointed as Executive Director of global rare disease advocacy group – March 2020
March 9, 2020
Optio attends CHDI – February 2020, Palm Springs, USA
February 27, 2020
Optio attends the Huntington Study Group annual meeting – November 2019, Sacramento, CA
November 27, 2019
JP Morgan Healthcare Conference, January 2019; Optio Biopharma Solutions conducts neurodegenerative rare disease asset valuation due diligence and other activities
January 15, 2019
The Huntington’s market heats up – observations as Optio attends the November 2018 HSG congress.
November 11, 2018
Optio attends Huntington’s Disease Society of America 33rd annual convention – Los Angeles, June 2018
June 6, 2018
Optio welcomes Ebo Dawson-Andoh; Executive Consultant, Pharma/Healthcare Survey Analyst – January 2018
January 15, 2018
Optio conducts social worker and caregiver focus group research at a neurological rare disease meeting – Chicago, IL.
June 21, 2017

All new engagements start with a meeting.

Let's Meet!
Optio Biopharma Solutions, LLC

Recent News

  • Optio attends Huntington’s Disease Society of America 37th annual convention – Atlanta, June 2022
  • Optio attends CHDI – February 2022, Palm Springs, USA
  • Eric Miller appointed as Executive Director of global rare disease advocacy group – March 2020
© 2024 Optio Biopharma Solutions, LLC. All Rights Reserved.